University of New South Wales
myUNSW

:: Class Utilisation Summary 2012


Subject Area Index

See LEGEND for key to shading and symbols.


:: Subject Area - OPTM  Term - Semester 1

OPTM0001 OPTM0002 OPTM2111 OPTM3111 OPTM3131 OPTM4110
OPTM4131 OPTM4151 OPTM4291 OPTM5111 OPTM5131 OPTM5151
OPTM5171 OPTM7001 OPTM7002 OPTM7003 OPTM7004 OPTM7005
OPTM7006 OPTM7103 OPTM7104 OPTM7108 OPTM7117 OPTM7301
OPTM7302 OPTM7308 OPTM7444 OPTM8009

Data is correct as at Wed Sep 26 19:11:12 EST 2012


Comp Sect Class Type Status Enr/Cap % Full Times (weeks, Location) - default 1hour 
OPTM0001   Research Thesis Optometry F/T
THE000111007EnrOpen27/60 45%  
OPTM0002   Research Thesis Optometry P/T
THE000111008EnrOpen17/60 28%  
OPTM2111   Optometry 2A
LAB001 6156EnrOpen19/20 95%   Mon 11-13 (w2-6,7-13, Myers 2009); Tue 14-16 (w2,3,4-6,7,8-13, Myers 3016); Tue 14-16 (w3,7, Myers 3016)
LAB002 6157EnrOpen18/20 90%   Mon 15-17 (w2-6,7-13, Myers 2009); Wed 09-11 (w2,3,4-6,7,8-13, Myers 3016); Wed 09-11 (w3,7, Myers 3016)
LAB003 6158EnrOpen18/20 90%   Thu 14-16 (w2,3,4-6,7,8-13, Myers 3016); Thu 14-16 (w3,7, Myers 3016); Thu 16-18 (w2-6,7-13, Myers 2009)
LAB004 6159EnrFull20/20 100%   Mon 09-11 (w2-6,7-13, Myers 2009); Wed 14-16 (w2,3,4-6,7,8-13, Myers 3016); Wed 14-16 (w3,7, Myers 3016)
LECA 6154RelOpen75/80 94%   Tue 13 (w1-6,7-11, Myers Thtr); Tue 13 (w12, Myers Thtr); Wed 16 (Myers Thtr); Fri 15 (w1-6,7-12, Myers Thtr)
OTHH09A 6155RelOpen75/80 94%   Thu 09-12 (w1); Thu 09-12 (w2-6,7-13, Myers 2030)
TUTGP1 6160AutoOpen19/20 95%   Tue 09 (w2,4,6,8-10,12,13, Myers 2030); Tue 09 (w3,5,7,11,13, Myers 2030)
TUTGP2 6161AutoOpen18/20 90%   Thu 14 (w2,3,4,5,6,7,8-10,11,12,13, RedC 3037)
TUTGP3 6162AutoOpen18/20 90%   Wed 15 (w2,4,6,8-10,12,13, RedC 3037); Wed 15 (w3,5,7,11,13, RedC 3037)
TUTGP4 6163AutoFull20/20 100%   Wed 11 (w2,4,6,8-10,12,13, Myers 2030); Wed 11 (w3,5,7,11,13, Myers 2030)
OPTM3111   Optometry 3A
LAB001 6165EnrFull23/20 > 100%   Tue 11-13 (w2-4,6,8,10,13, OMB 25); Tue 11-13 (w5,7,9,11-12, OMB 25); Thu 12-14 (w2-6,7-13, Myers 2009)
LAB002 6166EnrOpen14/20 70%   Mon 13-15 (w2-6,7-13, Myers 2009); Tue 09-11 (w2-4,6,8,10,13, OMB 25); Tue 09-11 (w5,7,9,11-12, OMB 25)
LAB003 6167EnrFull23/20 > 100%   Wed 12-14 (w2-4,6,8,10,13, OMB 25); Wed 12-14 (w5,7,9,11-12, OMB 25); Fri 09-11 (w2-6,7-13, Myers 2009)
LECA 6164RelOpen60/68 88%   Tue 15-17 (w1, CivEng G1); Tue 15-17 (w2-6,7-12, CivEng G1); Wed 09-11 (w1-4,6,10-13, Myers Thtr); Wed 09-11 (w5,9, Myers Thtr); Wed 09-11 (w7, Myers Thtr)
OPTM3131   Ocular Disease 3A
LAB001 6170EnrFull21/20 > 100%   Fri 14-16 (w4,9,11, OPTM CL)
LAB002 6171EnrOpen14/20 70%   Tue 11-13 (w4,9,11, OPTM CL)
LAB003 6172EnrFull22/20 > 100%   Tue 09-11 (w4,9,11, OPTM CL)
LE1A 6168RelOpen57/64 89%   Wed 14-16 (w2-6,7-13, Myers Thtr); Thu 14-16 (w2-6,7-13, MatSc G11)
LE2B 6169RelOpen57/64 89%   Fri 13 (w2-6,7-13, RedC M032)
OPTM4110   Optometry 4A
LAB501 6175EnrOpen12/22 55%   Wed 16-18 (w1-6,7,9-13, Myers 2009)
LAB502 6176EnrFull22/22 100%   Fri 14-16 (w1-5,7-13, Myers 2009)
LAB503 6177EnrOpen15/22 68%   Fri 11-13 (w1-5,7-13, Myers 2009)
LE2T16A 6174RelOpen49/53 92%   Tue 16-18 (w1-2, CLB 3)
LECA 6173RelOpen49/53 92%   Tue 16 (w4-5,7-9,12-13, CLB 3); Tue 16 (w10-11, CLB 3)
OPTM4131   Clinical Optometry 4A
LECA 6183EnrOpen49/53 92%   Mon 16 (w2-6,7-13, Myers Thtr)
OPTM4151   Ocular Therapeutics 4A
LAB501 6180EnrFull19/18 > 100%   Thu 10-12 (w5,7,10,12, OPTM CL)
LAB502 6181EnrFull18/18 100%   Fri 09-11 (w5,7,10,12, OPTM CL)
LAB503 6182EnrOpen12/18 67%   Fri 11-13 (w5,7,10,12, OPTM CL)
LE1A 6178RelOpen49/53 92%   Thu 14-16 (w2,4-6,7-13, Myers Thtr)
LE2B 6179RelOpen49/53 92%   Tue 14-16 (w2,4-5,6,7-8,9,10,11,12-13, Mat 102); Tue 14-16 (w3, Mat 102); Tue 14-16 (w6,9,11, Mat 102)
OPTM4291   Optom Med
LECA 3967EnrOpen43/53 81%   Mon 08 (w2-6,7-13, Myers Thtr); Tue 08 (w2-6,7-13, Myers Thtr); Fri 08 (w2-6,7-13, Myers Thtr)
OPTM5111   Clinical Optometry 5A
LECA 6184EnrFull45/45 100%   Mon 17 (w10-13, Myers Thtr)
OPTM5131   Specialist Clinical Optom 5A
LECA 6185EnrFull42/42 100%   Tue 15:30 (w2-6,7-13, Myers Thtr)
OPTM5151   Clinical Ocular Therap 5A
CLN00110098EnrOpen43/45 96%  
OPTM5171   Research Project 5A
OTH00110099EnrOpen40/45 89%  
OPTM7001   Intro to Community Eye Health
OTH000110141EnrOpen0/10 0%  
OPTM7002   Community Eye Health Needs Ass
OTH000110142EnrOpen1/10 10%  
OPTM7003   Epid of Blinding Eye Diseases
OTH000110143EnrOpen0/10 0%  
OPTM7004   Advocacy & Edu in Com Eye Hth
OTH000110144EnrOpen0/10 0%  
OPTM7005   Eye Hlth Econ & Sustainability
OTH000110145EnrOpen4/10 40%  
OPTM7006   Eye Care Program Management
OTH000110146EnrOpen10/12 83%  
OPTM7103   Behavioural Optometry 1
LEC000110125EnrOpen*15/30 50%  
OPTM7104   Adv. Contact Lens Studies 1
LEC000110126EnrOpen*13/30 43%  
OPTM7108   Research Skills in Optometry
LEC000110147EnrOpen2/30 7%  
OPTM7117   Ocular Therapy 2
LEC000110127EnrOpen98/120 82%  
OPTM7301   Advanced Clinical Optometry
LEC000110197EnrOpen*0/30 0%  
OPTM7302   Evidence Based Optometry
OTH000110149EnrOpen24/30 80%  
OPTM7308   Research Project
LEC000110148EnrOpen3/30 10%  
OPTM7444   Business Skills in Optometry
OTH000110485EnrOpen16/60 27%  
OPTM8009   Ocular Therapy
LEC000111189EnrOpen0/120 0%  
^ top ^
LEGEND
* This class requires consent. Students cannot self-enrol.
# Timetable clash allowed.
/odd  Runs in odd weeks only.     /even  Runs in even weeks only.
Comb/w Jointly taught with corresponding class(es) for specified course(s). Capacity shown is effective capacity.
      Effective capacity is the class capacity less any places taken by students in the other jointly-taught classes.
[  ] Class capacity where different from effective capacity.
  
Shaded cells:  LEC Activity different from previous
Stop Status is Stop Further Enrolment, Tentative, Closed or Cancelled
100%   Class is full (> 100% means capacity is exceeded)
80%   Class is nearly full (80% or more)
50%   Class is half full
0%   Class is less than half full
 

UNSW Sydney NSW 2052, Australian Telephone: (within Aust) 02 9385 1000, (International) +61 2 9385 1000
CRICOS Provider Code 00098G • Authorised by Deputy Vice Chancellor (Academic) & Registrar •  Privacy Statement •  Copyright & Disclaimer